Biotechnology Companies By Shares Outstanding

Shares Outstanding
Shares OutstandingEfficiencyMarket RiskExp Return
1HTDS Hard To Treat
5.48 B
 0.00 
 0.00 
 0.00 
2HLN Haleon Plc
4.62 B
 0.02 
 1.45 
 0.03 
3ABBV AbbVie Inc
1.77 B
 0.38 
 0.89 
 0.34 
4DNA Ginkgo Bioworks Holdings
1.64 B
 0.05 
 5.16 
 0.27 
5GILD Gilead Sciences
1.25 B
(0.06)
 1.83 
(0.11)
6ARYC Arrayit
1.13 B
 0.13 
 129.10 
 16.67 
7NWBO Northwest Biotherapeutics
1.05 B
(0.15)
 3.71 
(0.56)
8VPRO Viropro
916.09 M
 0.00 
 0.00 
 0.00 
9ROIV Roivant Sciences
805.85 M
 0.11 
 2.32 
 0.26 
10SMMT Summit Therapeutics PLC
701.7 M
 0.21 
 6.92 
 1.42 
11OPK Opko Health
696.99 M
(0.09)
 6.17 
(0.57)
12GRFS Grifols SA ADR
678.41 M
(0.07)
 5.42 
(0.41)
13IBRX Immunitybio
670.33 M
 0.09 
 7.89 
 0.73 
14GMAB Genmab AS
653.03 M
(0.11)
 2.10 
(0.23)
15DNAG DNAPrint Genomics
644.61 M
 0.00 
 0.00 
 0.00 
16GERN Geron
543.06 M
 0.08 
 4.75 
 0.39 
17CUBT Curative Biotechnology
537.88 M
 0.17 
 12.88 
 2.24 
18AMGN Amgen Inc
535.92 M
 0.02 
 1.39 
 0.03 
19CYBN CybinInc
410.86 M
(0.07)
 4.51 
(0.32)
20AMRN Amarin PLC
408.29 M
 0.12 
 6.89 
 0.84 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds. Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.